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3A B S T R A C T
(1 The properties of HCG in hydatidi 'orm mole were
studied in the present work and compared with
those in normal pregnant urine, as reported in
the literature by other workers.
(2) Certain properties are related:
(a) Molecular weight;
(b) NT-terminal amino acids;
(c) Amino acid composition.
{ 3) Certain properties are different:
(a) The total carbohydrate content in molar
HCG is higher;
(b) Glucose is present in molar HCG but absent
in urinary HCG;
(c) Blood-group A--like activity is detectable
in urinary HCG but not in molar HCG.
(1}) In view of (2) and (3), we are inclined to consider
the following which are of interest
(a) The primary structure of amino acids is
probably closely related whereas the
4carbohydrate side chain is believed to
be dhfferent;
(b) The qualitative and quantitative differences
in the carbohydrate side chain of HCG in
hydatidiform mole may play an important role
in the formation of this placenta disorder
(c) The presence of blood-group A-like activity
in urinary HCG of normal pregnancy has been
-postulated as to facilitate the implantation
of the fetus on maternal endo..ietrium. If
the above postulate is correct, it may be
reasonable tc, consider that-the absence of
this property in molar HCG may be the cause
of the early death of embryo in molar preg-
nancv.
(5) Futher studies along the following lines may prove
to be useful in better understanding of the aetio-
logy of hydatidiform mole:
(a) To'study the carbohydrate sequence of molar
HCG and the relationship between the carbo-
hydrate moiety and the immunological, bio-
logical and'serological activity.
5(b) To compare the effect of HCG isolated
from normal and molar pregnancy (in
urine, plasma and tissue) on interaction
with lymphocytes, which will provide
important information in the understanding
cif this nl acenta disorder.
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1T N T R 0 D U C T I O N
Human chorionic gonadotrophin (HCG) Is a Hormone
of glycoprotein in nature. It is produced by the
placenta. and present in significan:• quantities in the
urine during the first trimester of pregnancy (1,2).
This observation ha s led to the development of a number
of diagnostic tests fcr early detection of pregnancy,
based upon either biological or immunological activity
of the hormone.
Hydatidiform mole is a placental disorder in
which the HCG level is greatly elevated in urine and
blood usually it amounts two a 100-fold increase as
compared with that of normal pregnancy. In Hong Kong,
the incidence of hydatidiform riole is high (1-0242
deliveries) whereas in European countries and in the
United States is much lower (1:2,000) (3).
Chan (4,5) of this laboratory in his graduate
studies attempted to purify HCG in hydatidiform_mole
and made a literature survey up to early 1973. This
survey covers the following fields:
(•i) Pathology of hydatidiforri mole
(ii) Purification of HCG
(iii) Physico-chemical and biological properties
of HCG.
2As the present study is a continuation of Chan s
work, publications before early 1973 will only be cited
here when it is considered necessary. Since then, much
progress has been made on urinary HCG, particularly in
.the following aspects:
(i) Function of HCG during pregnancy
(ii) Chemistry of the carbohydrate moiety of HCG
(iii) Immunological and biological activities of
HCG
The survey of literature herewith included -therefore
aims at presenting a full picture of current research
on HCG since early 1973.
.In the present experimental. studies, we have
attempted to ascertain the carbohydrate moiety of the
molar HCG together with its immunological properti.es.
We have paid special attention to comparip-g these
.aspects of HCG obtained from hydatidiform mole and
normal pregnant urine. In addition, certain physical
properties of the pure molar HCG were studied.
3L I T E R A T U R E R E V I E W
PART A. FRACTIONATION AND STRUCTURE OF HCG
The principal difficulty encountered in the
purification of HCG is that there appears to be consider-
able heterogeneity, which is believed to be due principally
to the carbohydrate portion of the mo'Lecu]_e (6, 7). The
resultant heterogeneity in electrical charge leads to
starch-gel or polyacrylamide-disc-gel electrophoretic
patterns that exhibit either broad bands or multiple
bands. Hence the usual criteria for protein purity may
not be met with this glycoprotein hormone. However, the
amine acid composition of the protein portion of the HCG
molecule provides a means of comparing the characters-,ti.c s
of highly purified preparation of the hormone (6). In
order to provide a better background on fractionation
methods, the important ones are briefly stated below and
their essential :steps are summarized in Table 1.
(I) Method of Canfield, 1966 (6)
A 4-gram aliquot of commercial grade urinary HCQ with a
4biological activity of 2500-3000 IU/mg was dissolved
in 1 liter of 0.05M ammonium acet tte, pH 5.0. This
material was batch-adsorbed on SE-Sephadex C-50 on a
sintered-glass funnel. The ion exchanger was then
transferred to a chromatography column and the active
fraction eluted was lyophilized and passed through a
second column of Bio-gel P-150 in 0.0511 ammonium bi-
carbonate buffer at pH 5.0. The rod-uct was further
purified with DEAE Sephadex A-50 ion-exchanger equili-
brated with 0.02M ammonium bicarbonate buffer. 4 grams
of rude HCG yielded 400 mg of pure protein. This final
product showed a broad band on disc electrophoresis,
indicating heterogeneity of the hormone and with biologi-
cal activity of 13,000 IU/mg as measured by the rat
veitral prostate weight assay.
(II) Method of Bahl, 1969 (8)
A solution of 4.84 grams of commercial urinary HCG of
potency 3200 IU/mg in 25 ml of 0.02M tris-phosphate
buffer, pH 8.7, was applied to a DEAE-Sephadex A-50
column. The elution of the column was initiated with
0.04M tris-phosphate buffers of increasing pH and NaCl
concent.ation. The active fraction eluted was lyophilized
5and applied to DEAE-Sephadex A-50 column. The normone
was eluted with a linear gradient between 0.1M and 0.2M
NaCl in 0.04M tris-phosphate buffer at pH 8.3. The major
active fraction was lyophilized and subjected to further
purification by gel filtration of Sephadex G-100 with
0.04M sodium phosphate of buffer at pH 7.5. The yield
of purified protein from 4.84 grams of the crude urinary
HCG was about 0.92 grams with biological activity of
12.000 TU/wg as measured by the rat prostate gland method.
(III) Method of Mori, 1970-k9)
Commercial urinary HCG with biological activity
of 3,000 IU/mg was dissolved in a small volume of 0.02M
ammonium acetate buffer, pH 6.0. -The solution was
applied to a Sephadex G-100 column. The active fra•3tion
was subjected to further purification by rechromatograpb
on a DEAE-cellulose'column in 0.005M phosphate buffer at
pH 6.0 with gradient of NaCl concentration. An.apparentl y
homogeneous preparation of HCG with a biological potency
of 12.800 IU/mg was prepared.
(IV) Method of Pala, 1973 (10)
This report contains a method of purifying HCG
6from pregnant urine, peripheral plasma.and chorionic
tissue of a woman with hydatidiform mole. Urinary HCG
was extracted by the kaolin absorption procedure (11)
and the acetone precipitate was dissolved in a mixture
of 10% (wtr') ammonium acetate in 70% ethanol. The
supernatant solution was then mixed with 2.5 volumes
of*10%.(w/v) ammonium acetate in ethanol to precipitate
the crude HCG product. For the preparation of crude
molar HCG extract, the molar tissue after being washed
in 0.9% sodium chloride solution as hom.sgenized in
0.-1M phosphate buffer solution, pH 7.8. The total
homogenate was resuspended in four volumes of the
same buffer solution and again centrifuged. The final
crude sample was precipitated with five volumes of
cold ethanol. Further purification of the crude
urinary and molar HCG extracts followed the same
steps. They were batch-adsorbed to DEAE-cellulose
equilibrated and eluted with 0.05M phosphate buffe:c,
pH 7.0. The unabsorbed materials were dialysed and
lyophilized and were then applied to Sephadex G-100
column. equilibrated and eluted with 0.05M phosphate
buffer, pH 7.5. The active fraction was lyophilized
and redissolved in 0.04M-tris-adjusted to pH 8.7 with
0.04M KH„PO,. and subjected to further purification by
7DEAE-Sephadex A-50 ion exchange chromatography. The
development of the column was started with the same
buffer followed by a stepwise increase of 0.1M, 0.15M,
0.2M, 0.4M and 1N NaCl concentration.
(\T) Method of Chan, 1973 (4, 5)
This report containsa method of purifying HCG
from th-1- choriornic tissue of a woman with hydatidiform
mole. The salt precipitation procedure was adopted
from that devised by Papkoff et al. (43), using
(NH4)2S04 whereas the gel filtration procedure
followed essentially that of Bahl( 8), using DEAE
Sephadex A-50 anion exchange chromatography.





DEAE-Sephadex A-50 ionBio-gel P-150 Chromato-SE-Sephadex C-50Commercial(I) Canfeild
exchange chromatographygraphy in 0.05M NH4HCOin 0.05M CH3COONH4Crude HCG(1969)
in 0.02M NH4 HC3(normal preg-
nant urine)
Sephadex G-100 inDEAE-Sephadex A-50 inDEAE-Sephadex A-50(II) Bahl Commercial
linear gradient between 0.04M sodium phos-Crude HCG(1969) in 0.04M tris-PO4
phate buffer (pH 7.5)0.1M and 0.2M NaCl in(normal preg- of increasing pH
nant urine)
0.04M tris-P04 (pH 8.3)and NaCl conc.
DEAE-cellulose chromato-Sephadex G-100Commercial(III) Mori
graphy in 0.005M phos-chromatographyCrude HCG(1970)
phate (pH 6.0) with grad-normal preg- in 0.02M CH2 COONH4
nant urine)
ient of NaCl conc.(pH 6.0)
DEAE-Sephadex A-50 ionSephadex G-100 in 0.05M
DEAE-celluloseKaolin(IV) Pala
exchange chromatography
phosphate (pH 7.5)chromatography inabsorption(1973) in 0.04M tris-PO4
0.05M phosphateprocedure with gradient of NaCl(molar urine buffer (pH 7.0)
plasma and conc.
tissue)
9PART B. FUNCTIONS OF HCG DURING PREGNANCY
(I) HCG and glycogenolysis
It is suggested that HCG production starts in
the cytotrophoblastic cells and continues in the
syncytiotrophoblastic cells (12, 13). HCG is capable
of maintaining the corpus luteum, and its function in
the early stages of pregnancy appears to be.the rescue
of the stimulation of luteinized cells to produce
estrogens and progesterone (15). HCG is also found
to accelerate the biosynthesis of gonadal steroid
hormones (15). Recent studies by Cedard et al. (17)
suggested indirectly that the glycogen content of
human placental tissue at term may be rate limiting
in the supply of energy for aromatization in estrc,gen
biosynthesis. It was demonstrated that the addition
of HCG to the fluid perfusing term placentas elicited
a pronounced elevation in the glucose content of the
perfusate and increased the aromatization of androgenic
precursors of estrogens. They suggested that the
elevation in glucose may result from the breakdown
of endogenous glycogen in the tissue. The concept
that HCG mediates glycogenolysis in human placental
10
tissue had been directly demonstrated by Demers
et al. (19) by examining the effects of this hormone
on both the enzyme systeh that is responsible for
glycogen breakdown, glycogen phosphorylase and on
cyclic AMP content of this tissue following in
vitro exposure to HCG within 15 minutes of culture.
HCG consistently caused an increase in the active
form of phosphorylase, a decrease in placental
glycogen content and an elevation in placental
cyclic AMP content. It was also found that the
presence of prostaglandin E2 in the culture medium
evoked a similar glycogenolytic effect in immature
human placental villi including the increase in
tissue cyclic AMP level. This result, together
with the demonstration (19) of the efficacy of the
prostaglandins in stimulating human placental adenyl
cyclase activity, would suggest that at least the
E series of prostaglandins may play a second messenger
role in the expression of HCG. This second messenger
role of prostaglandins was suggested by Kuehl et al,
(20) In the mechanism of action of luteinizing hormone
on the corpus luteum. Placental glycogenolysis was
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then suggested to proceed via an HCG mediated, second
messenger prostaglandin E-carried, cyclic AMP-stimulated
phosphorylase cascade as shown by Sutherland et al.
(21) in the liver. HCG interacts with the placental
membrane possibly through a receptor eliciting a rise
in prostaglandins E which then effect an activation
of the adenyl-cyclase system to bring about an increase
in cyclic AMP and a sequential activation of the
phosphorylase cascade resulting in glycogen breakdown.
The proposed scheme suggested by Dermers et al. (18)

























Possible Mechanism of HCG-mediated
Glycogenolysis in human placenta
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(TT) HC and maternal lymphocyte suppression
The question which has been puzzling trans-
plantation biologists is the acceptance of the fetus
by the mother as an allograft when at least 50% of
,the fetal antigens are different from that of the
mother. The question of how the fetal trophoblast
can successfully engraft itself on the maternal
endometrium while it is constantly exposed to maternal
lymphocytes remains to be answered. It has been
suggested that the fetal trophoblastic antigens are
masked by a surface layer if mucoprotein which allows
the successful graft-host relationship (22). An
alternate hypothesis has been that pregnancy alters
the immunocompetence of maternal lymphocytes and..
thereby permits the implantation and the development
of the fetus (23). However, recent studies (24) have
presented conflicting evidence to the above hypotheses.
Recent studies by Naughton et al. (25) suggested
the possible role of HCG in-maternal lymphocyte
suppression during.the fetal implantation and develop-
ment. Plant lectin phytohemagglutinin (PHA)-induced
system which was standard test in evaluating lymphocyte
function was employed. Immunocompetent lymphocytes
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which, are exposed in vitro to PHA will be stimulated
to divide 125). This cell division can be assayed by
recording increase uptake of 3H-thym.L dine by the
lymphocyte cell culture.- A quantitative study of the
inhibition effect of HCG on the response of human
lymphocytes to PHA was undertaken. Their studies
indicated that HCG was a potent and reversible inhi-
bitor of the response of human lymphocytes to PHA and
that the inhibition occurs without cytotoxicity. Their
alternative study (26) further showed that this immuno-
suppression was specific as shown by the contrasting
response of lymphocyte to human serum albumin. HCG
in concentrations as little as 1 IU/ml caused some
effect, and the effect became marked at and above 100
IU/mi, which was within the range of the concentration
of HCG in human serum during the latter half of gestation.
Complete inhibition was found at 10,000 IU/ml. It has
been suggested (25) that trophoblasts from the-10-day
embryo could produce local concentrations, where the
maternal lymphocytes are in actual contact with the
trophoblasts, which far exceed 10,000 IU/ml. The
above data suggested that maternal lymphocyte immuno-
competence during pregnancy may be altered by HCG in
a reversible, noncytotoxic manner.
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PART C. THE CHEMISTRY OF GLYCOPROTEI
Glycoproteins are found in plants as well as
in animals and their chemistry has long been studied.
The most intriguing group of glycoproteins nw being
investigated are thosa found on the surfaces of the
.cells. Although ::n mass they are only minor consti-
tuents of the membranes of animal cells, they are
important because they are responsible, at least in
part, for communicating the individuality of the cell.
The glycoproteins coating on the cell may serve as
antigenic determinants, .s virus receptors and as
markers of cellular identity. The following is a
brief review on some aspects of the general chemistry
and metabolism of glycoproteins* (27, 28).
(I) Linkage of Oligosaccharide
Seven kinds of monosaccharides are found in
glycoproteins. They are D-glucose., D-galactose,
D-tr.annose, L--fucose, N-acetyl-D-galactosamine, N-
acetyl-D-glucosamine and N-acetyl-neuraminic acid.*
It is found that certain linkages occur very fre-
quently in mammalian glycoproteins. An especially
frequentl occurring structure is the heteropoly-
16
saccharide consisting of the sequence
sialic acid (or fucose)- galactose---N-acetyl-
glucosamine-- mannose
Three types of peptide-carbohydrate bonds have
been demonstrated in mammalian glycoproteins (Fig. 2).
The first of these if the N-glycosidic linkage between
the carbon of acetyl glucosamine and the amide group
of asparagine. This type of bond is found in the
circulating plasma proteins synthesized in the liver
as well as in the circulating immunoglobu].ins, ovalbumin,
ribonuclease B and many other glycoproteinS. The second
type is an -0-glycossidic linkage between the anomeric
carbon of N-acetyl-galactosamine and the hydroxyl group
of serine and threonine. This linkage occurs in most
of the epithelipl mucins, the blood group substances
and also in the major glycoprotein of human erythrocytes.
HCG and immunoglobulins- have been shown to have both
the N-glycoside and 0-glycoside typo of linkage. The
third type consists of a (3 -linkage between the reducing
group of galactose and the hydroxyl group of hydroxy-
lysine. This linkage has been demonstrated in collagen
and in basement membrane (29).,
Fig. 2. Carbohydrate peptide linkages. (A) N-glycoside




























TT) M e-rnhafprc)creneitv of ,zlvcoprotein
Two kinds of microheterogeneity are-found in
the oligosaccharide chains. The first type was due t4
differences in composition of the oligosaccharide.
Cunningham et al. (30) in 1965 found markedly diff-
erent ratios of mannose to acetyl glucosauine in
glycopeptides prepared from ovalbumin. The variation
represent the incompleted oligosaccharides. Most
glycoproteifi exhibit microheterogeneity of this type
(31, 32). Another type of microheterogeneity irises
from positional isomerism. It was found that hunan
plasma orosomucoid may contain N-acetyl-neuraminic
acid linked to galactose in 2-3, 2-.4, or 2 -6
linkage. This positional isomerization of sialic
acid has been proposed to be associated with diff-
erences in pK values of the sialic acid and thus
to account for-the electrophoretic v riants of
glycoproteins.
(III)Biosynthesis of Oligosaccharide
.The microheterogeneity of the carbohydrates
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of glycoproteins is a direct consequence of the
mechanism of their synthesis. This process begins
with the formation of the polypeptide part of the
molecule like all other proteins it is assembled
at the ribosome on.a template represented by DNA
and RNA. It is well established that the formation
of the oligosaccharide chains occurs as a result
of the. sequential transfer of glycosyl group from
sugar nucleotides to specific acceptors in the
growing oligosaccharide chains (33). It is suggested
that most of the transferases involved in these tran-
glycosylatior.s are membrane bound. It would appear
likely that the innermost N-acetyl-glucosamine and
mannos. are first added to the growing oligosaccharide
chain and, as the glycoprotein moves through the
channels of the endoplastic reticulum and the Colgi' s
apparatus,. the membrane-bound transferases attach
one sugar at a time to the oligosaccharide units.
The specificity of the glycosyltransferases are not
rigid. The reactions are also influenced by environ-
mental factors, such as the relative abundance of. the


































Fig. 4. Linear amino acid sequence of HCG
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On the basis of studies on several glycoproteins
(33), the invariant sequence around the asparagine has
been found to be -Asn-X--Thr (or Ser)- and this has been
postulated as the recognition site for the enzyme which
attaches N-acetyl-glucosamine to the amide group of
asDaragine in a N-glycosidic linkage.
(IV) Chemistry of the carbohydrate moiety of urinary
HCG
The carbohydrate contents of urinary HCG in
normal pregnancy were repo%•ted by various authors
(8, 34, 14). It contains approximately 30% carbo-
hydrate, namely, fucose, galactose, mapnose, gluco-
samine, galactosamine and siali--.acid. They are
distributed in seven carbohydrate units (16), four
of them being li,lked N-glycosidically to the asp-
araginyl residues and the remaining three 0-glyco-
sidically to the seryl residues. The aspa ragine
linked carbohydrate units are bulky, complex and
multiple-branched and are'located at position 52
and 78 (Fig. 3) in the d subunit and at position 13
and 30 (Fig. 4) in the j subunit. The serine-linked
carbohydrate units are short, linear oligosaccharide
chains and are present only in the (3 subunit at
position 118, 129 and 131.
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The carbohydrate moiety of urinary HCC represents
two of the limited numbers of structural patterns pre-
sent in glycoproteins. The asparagine-linked carbo-
hydrate units have similar structural features as
those present in serum glycoprotens such as . -acid
.glycoprotein and fetuin, whereas the serine-linked
carbohydrate units are representative of mucins and
blood-group substances (16). Urinary HCG has two types
of protexa-polyaaccharide linkages in the same mole-
cule. On y a few other examples of glycoproteins of
this type have been reported thus far (35).
23
PART D. IMMUNOLOGICAL AND BIOLOGICAL ACTIVITY OF HCG
HCG is composed of 2 subunits, and (36). The
subunit is hormone-specific, while the subunit is com-
mon to the other glycoprotein hormones (37). Recently,
amino acid sequences of both subunits of HCG have been
completed by Bahl et al. (38, 39, 40). The dissirnilarit
of the subunits and the noncovalent nature of their
attachment were established by the separation of the
and subunits from the native hormone on DEAE-Sephadex
after incubating the native hormone in 8 M urea and by
their recombination (36, 41). Inactivation of HCG by
urea has been reported by several laboratories and was
presumably due to the dissociation of tree hormone into
its subunits. The reconstituted HCG was indistinguish-
able from native HCG in electrophoretic, immunological
and biological properties (41).
Recently, an interesting picture of the interrelation-
ships among various glycoprotein hormones has been esta-
blished. It has been shown that thyroid stimulating
hormone (42), HCG (36, 6), luteinizing hormone (43, 44)
and follicle stimulating hormone (45) are all composed
of two noncovalently bonded subunits designated and
The subunits of HCG, luteinizing hormone, and
thyroid stimulating hormone are interchangeable. The
24
interchangeability of the X subunits would also suggest
that they must have a high degree of structural similar-
ity. The X subunits of HCG, LH and TSH show considerable
homology (39). It is evident that the B subunits deter-
mine the specificity of the hormones. These findings
provide the basis for a concept of glycoprotein hormone
action in which specific tissue recognition and binding
properties are conferred by the unique B subunits, and
more general functions, such as hormone transport or
receptor activation, have been proposed for the X sub-
unit. The high specificity of glycoprotein hormones for
their receptor sites in normal target tissues has been
shown to depend upon the B subunit by re-association and
hybridization experiments, in which the hormonal charact-
eristics of various combinations of X and B subunits have,
always been determined by the origin and nature of the
subunits (46).
LH and HCG show similar biological activity in
many aspects (47, 48, 49). It was found that the
sequence of HCG-B (40) has a high degree of homology
with LH-B (50), but has 28 additional residues at
the C-terminus, Since HCG-X can associate with LH-B
with no apparent loss of LH activity, it appears that
25
the 28 extra C-terminal residues are not involved in
the binding of the subunits and may also not be re-
quired for the LH activity. However, this region
appears to be involved in the immunological behavior
of the molecule. It has recently been reported that
rabbit anti-HCG- can discriminate immunologically
between HCG and LH (51) and this is :he basis for a
radioimmunoassay of HCG and LH (52). Furthermore, HCG
has been reported to have FSH-like activity (53, 54,
55, 56, 57), and it is conceivable that the C-terminus
(28 residues) contributes the major difference in
activities between HCG and LH.
The role of the carbohydrate moiety in relation
to the biological activity of HCG has been little
understood and remains to be investigated. The sialic
acid is associated with the biological activity of the
HCG molecule. The removal of the terminal sialic
acid by neuraminidase inactivates about 90% of the
biological activity (58, 59). It is not known whether
the sialic acid in both and subunits of HCG is
equally important. The indirect evidence derived from
recombination experiments (35) indicated that at least
it may not be necessary in the subunit of HCG since
this can be replaced by the ( subunit of bovine LH which
26
has a negligible amount of sialic acid. In contrast
to the reduction in biological activity measured in
vivo, immunological activity of HG-measured in vitro
is unaffected by complete desialylation (59, 60, 61)-
It has been shown that progressive desialylation of
HCG is accompanied by both progressive decrease in
biological activity and progressive decrease in plasma
half-life of the hormone (60). The marked reduction
in biological activity (in vivo) of HCG and other
gonadotropins following neuraminidase treatment is
probably due to increased hepatic uptake of the de-
sialylated hormone as suggested by Morell (62). The
exposure of terminal, non-redu:ing galactosyl residues
by removal of sialic acid provides a means by which
the liver recognizes and removes the defective molEe-
cule from the circulation (62). Recently, the locus
of binding has been shown by Ashwell (63) to reside
in the plasma membranes of hepatic parenchymal cells.
A detailed investigation of the properties of this
system-revealed the surprising finding that enzymatic
.hydrolysis of the membrane-bound sialic acid resulted
in complete loss of binding activity for asialo-glyco-
proteins (63). From these stadies it becomes clear
27
that sialic acid plays-a complex and mutually.exclusiv,
role in determining the metabolic fate of specific
circulating glycoprotein. Effective hepatic uptake
requires not only the absence of sialic acid on the
glycoproteins but, in addition, the presence of this
substituent on the plasma membrane.
There is another significant immunological
property of urinary HCC that has recently been
discovered. Marz et al. (64) reported that urinary
HCG possesses blood-group A-like activity which'is
located in the c(-subunit of the hormone containing
no N-acetyl-galactosamine, a component necessary for
the blood-group A activity. It should be pointed out
that urinary HCG is the first hormone which has been
found to exhibit blood-group activity. The precise
p.aysiological significance of their studies is not
yet clear, but it is fascinating in view of the
possible role of HCG in the suppression of lymphocyte
function during the implantation of the fetus on mat-
ernal endometrium (25).' The question which has been
puzzling transplantation biologists is the acceptance
of the fetus by the mother since the fetal antigens
are potentially different from those of the mother.
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It has been postulated that HCG might be involved in
the suppression of the immunoresponse by bind-.ng with
f1
maternal lymphocytes (25). Marki et alo (64) have not
determined the structural component required for the
A-like activity, but they believe that the carbohydratE
moiety of urinary HCG seems to be associated with the
serological activity. Since molar HCG shows certain
differences in physical properties from that of urinary
origin ana hydatidiforin mole is actually a disorder of
• pregnancy, it would therefore be interesting to inves-
tigate whether blood-group A-like activity is present
i' molar HCG.
29
M F T H 0 D A N D M A T E R I A L 116
PART A. PURIFICATION OF MOLAR HCG
The method used here to obtai-.i a pure pre-
paration of molar HCG followed that of Chan, Lee and
Ma, 1973 (4,5). The salt precipitation procedure was
adopted from that devised by Papkoff et al,, 1967 (43),
using (NH4)2S04 whereas the gel filtration procedure
followed essentially that of Bahl, 1969 (8), using
DEAE Sephadex A-50 anion exchange caromatography.
The hydatidiform mole from which the HCG was
obtained came from a patient of 46 years old. She had
no previous history of hyda+idiform mole and had given
b2ihy
birth to two children. The tissue afterAcarefully
washed with cold isotonic saline to remove blood was
homogenized an,1 lyophilized.
5 grams of freeze-dried molar tissue after belr
suspended in 500 ml of 0.15M ammonium sulphate solution
was adjusted to pH 4.0 and stirred overnight at 40.
The mixture was centrifuged at 10,000 x g for 20 min.
and the supernatant was then adjusted to pH 3.0 with
freshly, prepared 0. 5M H PO 4. After: further centri'-
3
fugation the supernatant was then stirred for-two hours
before centrifugation at 10,000 x g for 30 minutes.
The precipitate was dissolved in 100 ml of 0.2M K2HPO4
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solution followed by dialysis and lyophilization. The
crude product was further purified by passing through
a Sephadex G-200 column (2 x 150 cm) in 0.05M NH4HC0V
buffer. The active fraction was lyophilized and re-
dissolved in 0.05M tris-phosphate buffer at pH 8.6 and
sub j ect.. d to further purification by DEAE Sephadex
A-50 anion exchange chromatography (2 x'30 cm) in the
same buffer followed by increasing NaCl concentration
tf the buffer to 0.2M. The active fraction was lyo-
philized and re-suspended in 0.05M tris-phosphate buffer
at pH 7.0. It was further purified by applying to
.DEAE Sephadex A-50 anion exchange chromatography (2 x 30
cm) in the same buffer followed by increasing NaCl con-
centration of the buffer to 0.5M. The extent of puri-
fication was continuously monitored, exclusively by
immunoassay, using'the commercial UCG titration test
kit (Wampole Laboratories, Stamford, Conn., U.S.A.,
with a stated sensitivity of 0.8 I'J/ml) based on the
hemagglutina'ion principle.
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PART B. PHYSICAL PROPERTIES OF MOLAR HCG
(I) Molecular weight determination
The molecular weight of molar HCG and its subunits
were determined by sodium dodecyl sulphate (EMS) gel
electrophoresis (66, 67). The samples were incubated
'for two hours, at 37 0, at a protein concentration of
1 mg/ml, using the following incubation media: (a)
4 M urea and 1% (w/v) SDS in 0.01 M NaH2PO4. at pH
7.0 (b) 4 M urea, 1% (w/v) SDS and 1% (w/v) 2-mer-
captoethanol in 0.01 M NaH2PO4 at pH 7.0. The
molecular weight of molar HCG was determined using
medium (a), while it was dissociated by 2-mercapto-
ethanol in the presence of 4 M urea and 1% SDS (i.e.
medium b). For electrophoresis, the gel buffer con-
tained 7.8 g NaH2P04.H20, 38.6 g of Na2HPO4 7H20
and 2 g SDS per liter. For the 10% acrylamide solution,
22.2 g of acrylamide and 0.6 g of methylene-bisacrylamide
were dissolved in water to give 100 ml of the solution.
The-gel tubes were 10 cm long with an inner diameter
of 6 mm. For a typical run of 12 gels, 15 ml of gel
buffer were deaerated and mixed with 13.5 ml, of acryl-
amide solution. Further deaeration was carried out and
1.5 ml of freshly made ammonium persulfate solution
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(15 mg/nil) together with 4.5 )a 1 of N,N,N,N 1 -.tetra-
methylethylenediamine were added. After mixing, each
tube was filled with 2 ml of the solution and allowed
to harden. Approximately 30 }al of the protein solution
were applied on the gels. Gel buffer, diluted 1: 1
with water, was carefully layered on the top of each
sample to fill the tubes. The two cornpartmen-.:s of the
electrophoresis apparatus were filled with gel buffer,
diluted 1: 1 with water. Electrophoresis was performed
at a constant current of 7 mA per gel with the positive
electrode in the lower chamber. Cytochrome C, chymo
trypsinogen, bovine serum albumin, myoglobin, ovalLumin
(Schwarz/Mann Co., U.S.A.) were used as standards and
treated the same manner as the stmples. The electro-
phoretic run was completed until cytochrome C moved
thA.-ee-quarters through the gel. After e.'.ectrophoresis,
the gels were removed from the tubes by squirting water
.from a' syringe between the gel and.glass wall. The gels
were then stained in 0..25%.Amido Black 10.B in a solution
of methanol-glacial acetic acid-water, 1:3:10 for 10
hours. The solution made of methanol-glacial acetic
acid-water, 1:3:10 was used as destaining solution.
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Relative electrophoretic mobilities of the protein
markers were calculated, using cytochrome C as the
reference. The relative electrophoretic mobilities
were plotted against their logarithms of molecular
weights of the protein markers, from which the mole-
cular weight of molar HCG and its subunits were
estimated.
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(II) Absorption Spectrum and Extinction Coefficient
The molar HCG preparation was dissolved in 0.05M
NH4HCO3 buffer. The absorption of the solution from
200 to 400 nm was determined with a double beam spec-
trophotometer (Jasco Model ORD/CD-5, Japan) using 0.05M
NH4HC03 as references.
Extinction coefficient of molar HCG was deter-
mined on a weight basis. Dried sample of about 3 mg
was weighed out ; after dissolving with 3 ml of 0.05M
NH4HCO3, the absorbance at 280 nm was determined with
a spectrophotometer (Beck nan Model DU-2). The extinction.
1%
coefficient E (the absorption for a 1% solution
1cm
through a path length of 1 cm) was calculated. The
molar extinction coefficient EM• was also calculated
1%
from the E 1cm value and the molecular weight of the
sample measured by sodium dodecyl sulphate (SDS) gel
1%
electrophoresis. The relationship between E
1cm




(III) Amino Acid Composition Analysis
Aino acid composition analysis of purified molar
HCG was performed by the method of Moore et al. (69).
Samples of 1 mg were hydrolyzed with constant boiling
HC1 for 22 and 72 hours at 1100 in sealed vacuum tubes.
After hydrolysis the acid was removed in vacuo at room
temperature. The dried hydrolysate was dissolved in a
measured volume of sodium citrate buffer (0.2 N Na+)
at pH 2.2. Suitable aliquots were taken for chromato
graphic analysis of amino acids using an amino acRd
analyzer, Beckman Model 120 C. Acidic and neutral amino
acids were analyzed on the long column (0.9 x 56 cm,
Beckman AA-15 resin), eluted at a total flow rate of 102
ml/hr with a change of sodium citrate buffer from pH
3.25 (0.2 N Na+) to pH 4.25 (0.38.N Na+). The basic
amino acids were analyzed on the short column (0.9 x 6
cm, Beckman PA-35 resin) eluted at a total flow rate of
102 ml/hr with sodium citrate buffer (0.35 N Na+) pH
5.25.
The presence of any free sulfhydryl groups was
determined by carboxamidomethylation of the protein (8).
A sample of 1.5 mg of the hormone, in 1 ml of 0.05 M
36
sodium phosphate buffer, pH 8.4, and 3 M urea, was
allowed to react with 3 mg iodoacetamide. The mixture
was incubated for 6 hours.at 37°. After being dialyzec
against running distilled water, the dialysate was lyo-
philized. It was then hydrolyzed with 1 ml constant
boiling HCl in a sealed vacuum tube for 22 hours at 110.
The hydrolysate wau analyzed with the Beckman amino acid
analyzer (Model 120 C). Tryptophan analysis was not
performed.
Dot-counting method was used to evaluate the peak
areas on the chromatograms. The amino acid composition
of molar HCG was determin.d by means of two time intervals
of hydrolysis, viz. 22 and 72 hours residues of threonine,
serine, half-cystine, methionire and tyrosine values were
calculated by extrapolation to zero time. of hydrolysis
(105).
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PART C. QUALITATIVE AND QUANTITATIVE ANALYSIS
OF CARBOHYDPATE CONTENT OF MOLAR HCG
(I) Qualitative Analysis
(a) Neutral and amino sugars
A 0.5 mg sample of molar HCG was hydrolyzed
at 1000 for 8 hours with 1 ml 1 N HCl in an evacuated
sealed tube. The hydrolyzate after dilution to a
volume of 5 ml with distilled water was applied to a
Dowex 50(H+), 20-50 mesh cation exchange resin column
(1.5 x 10 cm). The amino sugars and basic amino acids
were adsorbed. 100 ml of distilled water were added
after the hydrolysate had passed through. The effluent
of the hydrolysate containing the neutral sugars and
acidic amino acids were further applied to a Dowex 1
(HCO), 20-50 mesh anion exchange resin column (2.5 x
10 cm) where the acidic amino acids were adsorbed
while the neutral sugars in the effluents were col-
lected by subsequent elutions with HCl of the following
volumes and concentrations (70): (a) 5 ml of 2 N, (b)
10 ml of 1 N, (c) 15 ml of 0.5 N and (d) about 20 ml of
0.25 N HC1. The neutral sugars and amino sugars col-
lected were lyophilized. The residue was then examined
by paper chromatography on Wnatman No. 1 papers. The
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solvent system for neutral sugars was prepared by
mixing ethyl acetate- pyridine- water, 8:2:2 (v/v)3
using the upper phase (71) while for amino sugars,
ethyl acetate- pyridine n-butyl alcohol- n-butyric
acid- water, 10:10:5:1:5 (v/v) (72). Alkaline. silver
nitrate was employed as the spray reagent for the
detection of sugars (73)
(b) Specific Test for Glucose
The presence of glucose in the molar HCG hydro-
lysate was also determiner'. enzymatically. Dextrostix
Reagent Strips (Ames Co., Miles Lab. Inc., U.S.A.),
which contained a glucose oxidase, peroxidase and a
chromogen indicator system under a semi-permeable






The molar HCG preparation was dried under reduced
pressure to constant weight in a vacuum desiccator. 1 m
of the sample was accurately weighed out. For neutral
sugars analysis, 1.2 ml of 1 N HC1 were added. The
tube was sealed under reduced pressure and was hydro-
lyzed at 100 0 for 2 hours (7, 8). For amino sugars
analysis,' the sample was hydrolyzed with 1 ml of-2 N
HC1 at 105° for 5 hours (14, 34). After cooling, the
tube was opened and 0.2 ml of the internal standard
solution was added. Arabinose (0.25 P mole) was used
as internal standard for neutral sugars and mannosamine
(0.10 p mole), for amino sugars.
Dowex 1 of bicarbonate form was prepared from
Dowex 1 (X 8), chloride form of 100-200 mesh sizes.
This was heated for 30 min. at 100 0 with 2 N NaOH,
stirred overnight at 20°, and washed with water. The
resin was then shaken for 1 hour with saturated KHCO3
and filtered off. It was resuspended in fresh bi-
carbonate, gassed with carbon dioxide for 1 hour,
collected on a filter, and 'stored under 0.2 M KHCO3
It was washed with water immediately before use (74).
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The molar HCG hydrolysate was ccmpletely trans-
ferred to a 50-ml beaker. Freshly washed Dowex 1
(HC03 was added, with constant stirring, until the
pH rose to between 6.0 and 6.5 (4). The resin was
removed by filtration through a Buchner funnel, it
was washed in the funnel with 10 ml of distilled water
The filtrate combined and washings were collected in
a 25-ml pear shaped flask.
Alditol Acetate of Carbohydrate
The carbohydrate content in the acid hydrolysate
of molar HCG was examined by means of gas liquid
chromatography. The alditol acetate derivatives of
the neutral and amino sugars were used ire the analysis
(75, 76, 77, 78-.), The carbohydrate filtrate and w=ash-
ings were allowed to cool to 40 and 10 mg sodium boro-
hydride was added. Reduction was allowed to proceed
overnight in the cold. 0.2 ml of constant boiling
HC1 was added to decompose-the.excess sodium borohydride.
After the solution was lyophilized, approximately 5 ml
of methanol was added to the dry residue in order to
convert the boric acid to the volatile trimethyl
borate. Methanol was removed under reduced pressure
at room temperature and the methanol treatment was
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repeated 12 times. To the dry residue was added 1 ml
of a 1: 1 solution of pyridine and acetic anhydride.
The tube was capped and acetylation was complete after
incubatinc at 1000 for 15 min. After cooling t3 room
temperature, 1 ml of distilled water was added. The
pyridine together with the water was evaporatedunder
reduced pressure. The water treatment was repeated
for 10 times. The dry residue was dissolved in 250 p11
of chloroform. The tube was centrifuged and 2.0 to
10.0 p1 of the clear supernatant was injected into the
gas column.
The alditol acetate derivatives of the standard
carbohydrate were also prepared. For neutral sugars
analysis, 0.80 ml standard solution was prepared to
contain fucose, mannose,'galactose and glucose in
approximately the same pro, ortions that they may occur
in molar HCG, viz. 0.25), mole of neutral sugars. 0.20
ml internal standard solution containing 0.25 p. mole
of arabinose, and 0.2 ml constant boiling HC1 were
added. For amino sugars analysis, 0.80 ml standard
solution was prepare to contain 0.10 11 mole of. gluco-
samine and galactosamine. 0-.20 ml internal standard
solution containing 0.10 )1 mole mannosamine and 0.2 ml
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of constant boiling HCl were added. The standard
solutions were neutralized with Dowex 1 (HCO
reduced with sodium borohydride, lyophilized, and
acetylated in the same way as the glycoprotein wac
treated.
Cas Chromatography
A Hewlett-Packard model 402 B gas chrornatograph
equipped with a dual-flame ionization detector-with
single channel electrometer and 6 feet U-shaped
gass columns. The columns used in this study include
the following:
Column 1: 3% ECNSS-M on 60/80 mesh Gas Chrom Q
(Applied Science Labs., State CoIlege,
Ohio, U.S.A.)
Column 2: 3% Poly A-103 (polyamide) on 100/120
mesh Gas Chrom Q
(Applied Science Labs., State College,
Ohio, U.S.A.)
Column 1 was employed for neutral sugars analysis
(77) while column 2 for amino sugars (78). The con-
ditions for gas chromatography were shown in Table 2.
Table 2. Conditions For The Gas Chromatography
Conditions Column 2(3% Poly A-103)Column 1 (3% ECNSS-M)
Column Temperature 200 240
constantconstantTemperature program
Detector temperature 260 280
0
Flash heater temperature 280 300
45 ml/min35 mi/ininHydrogen flow (to detector)
300 ml/minAir flow (to detector) 350 mi /min
60 ml/min60 mi /minCarrier gas (helium)
10 2 x 210 2 x 16Electrometer attenuation and range
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The results were calculated using the following
relationship (79)
% X in protein
where X = carbohydrate for which analysis was being
done,
Ax= area of peak representing carbohydrate for
which analysisas was being done. and
Ais= area of peak representing internal standard
carbohydrate.
(3) Amino Acid Analyzer
The hexosamines were also determined by amino
acid analyzer. Molar HCG sample was dried under reduced
pressure to constant weight in vacuum desiccator. Exactly
0.5 mg sample was accurately weighed out. 1 ml of 2 N
HC1 was added. The tube was sealed under reduced press-
ure and was hydrolyzed at 105 for 5 hours (14, 34).
The hydrolysate was freed of amino acids and neutral
sugars by the method of Boas (70): the hydrolysate
after diluted to 1 N HC1 with distilled water was
transferred to a Dowex 50 (H), 20-50 mesh cation ex-
change resin column (1.5 x. 10 cm); the effluents of
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hydrolysate and the washed water contained the inter-
fering substances and were discarded and the hexosamines
were eluted with HCl of the following volumes and con-
centration: (a) 5 ml of 2 N, (b) 10 ml of 1 N, (c) 15 ml
of 0.5 N, and (d) about 20 ml of 0,25 N HCl. The flow
rate*was adjusted at about 5 ml per 40 min. and the
effluents were lyophilized. After dissolving the residue
in 500 )1l of sodium citrate buffer (0.2 N Na+), pH 2.2,
250 jil of the resulting solution was applied to a short
column, 23 x 0.9 cm (Beckman PA-35 resin, particle size
13 +6u, cross linkage 7.5%) of the Beckman amino acid
analyzer (Model 120 C). The hexosamines were eluted at
a total flow rate of 102 ml/hr with sodium citrate buffer
(0.35 N Na+), pH 5.2. Standards of glucosamine and
galactosamine were adjusted to 1 N. HCl and treated in
the same manner as the sample. Dot-counting method was
used to'evaluate the peak areas on the chromatograms.
46
PART D. IMMUNOLOGICAL PROPERTIES OF MOLAR HCG
(I) Immunological Properties of uicinary and molar
HCG
The immunological -)roperties of urinary and molar
HCG were determined by double immunodiffusion following
the method of Ouchterlony (80). Antiserum was obtained
by repeated subcutaneous injections of commercial urinary
HCG (Sigma Chemical Co., Stock No. CC-10, 10,000 IU per
tube) of 1,000 IU in 1 ml of a 1:1 (v/v) mixture-of sterile
saline and Freund s complete adjuvant. The sera became
useful when it had an antibody titer of -1:103-104 by a
hemagglutination test (Pregnosticon Planotest Kit, Organon,
Holland). Antibodies to nonspecific components were
removed by absorption with lyophilized urinary proteins
obtained from HCG-free female urine. The anti-HCG gamma-
globulin was further concentrated by precipitation with
40% saturation ammonium sulphate. A 1% agar (Serva Co.)
solution in phosphate buffer saline was used for setting
the agar plate in a Petri dish. A 7 mm diameter central
well and 4 circumferential wells of the same diameter
arranged at the corners .of a regular square on the agar
plate were cut. To the central well, HCG-antiserum was
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applied. The gel plate was observed for precipitation
lines after 10 days of incubation at room temperature.
(II) ABO Blood Group Activity of Molar CG
Blood Specimens
The serologic. properties of the normal blood
were screened following.the method of Taylor et al.
(81), using standard immune anti-A and anti-B human
serum (Ortho Diagnostics, New Jersey, U.S.A.). The
native non-immune anti-A and anti-B serum were then
obtained from these screened blood specimens (81).
3% phosphate buffered saline solution, pH 7.35 (PBS)
group B red blood cells were also prepared (81). 3%
PBS group A2 erythrocytes suspension were obtained
from Ortho Diagnostics (Ortho A2 cells, Ortho Diagnos-
ties, New Jersey, U.S.A.).
Saliva Sample
Since salivas from blood group A secretor give
positive reaction to cross-wtching, it has been com-
monly used as a control to test the ABO .blood group
activity of urinary HCG (64). Hence in the present
experiment, a sample of saliva from blood group A
secretor was employed for this purpose.
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After first rinsing the mouth thoroughly
with the distilled water,. a male blood--group A
secretor donor of age 24, expressed saliva directly
into a beaker. The native saliva specimens were
placed in a boiling water bath for 90 seconds. After
cooled, the inactivated saliva. samples were centri-
fuged at 17,000 g for 25 min. at 4° in order to remove
the aggregated debris and heat-coagulated material.
The supernatants were stored under -25 until use.
Urrinaryi d molar HL(i preparation
3% PBS (v/v) solution of purified molar HCG
samples were employed. Since urinary HCG had been
reported to possess blood-group A activity (64),
commercial urinary HCG (Sigma Chemical Co., Stock No.
CC-10, 10,000 IU per vial) were'used without any
further purification. Each vial of urinary HCG was
dissolved in 150 }1l PBS solution and 70 )1l aliquots
were used in the test.
Titration of anti-A and anti-B blood grouping serum
The method used was a slight modification of
that described by Taylor et al. (81). The titrations
were carried out in precipitin tubes. The native
non-immune), human anti-blood grouping serum prepar-
ation was serially twofold diluted with PBS solution
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the resulting solution was divided into two equal
parts. To each part, equal volume of 3% PBS blood
grouping red blood cell suspension was added, mixed
and stooe at room temperature for two hours. Group
A2 (Ortho A2 cells, Ortho Diagnostics, New Jersey,
U.S.A.) and B erythrocytes were used. The.titration
value of the antiserum was determined microscopically
Determination of ABO blood group-activities.
The hemagglutination inhibition-technique was
used following the method of Boorman et al. (82)0
The principle of the test was based on the comparison
of titration values of native (non-immune), human
anti-A and anti-B sera before and after the addition
of urinary and molar HCG. The titrations were carried
out in precipitin 'tubes. The anti-A and anti--B blood
grouping serum was serially serologic twofold diluted
with PBS solution the-resulting solution was
divided into two' parts. To each part, one volume
of 3% PBS (w/v) solution of molar HCG were mixed.
One volume of urinary HCG were also added in another
set of diluted antiserum for comparison. These mixture
for agglutination.
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were allowed to stand at room temperature for 30 min.
An equal volume of the appropriate 3% red blood cells
(group A2 and B red blood cells) were added to all
the tubes and they were incubated further for two
.hours at room temperature. They were then screened
for microscopic agglutination.
For further investigation of ABO blood
group activity of urinary and molar HCG, another
liemagglutination method of Moh.n et al. (83) -was used.
Twofold serial dilutions in PBS solution of 3% (w/v)
molar HCG sample with an equal volume of native .(non-
immune), human anti-A serum which was preselected
to have a titer of 32 in the preliminary titration
carriec out immediately prior the assay. The mixtures
were allowed to stand at room temperature for 30 min.
An equal volume of 3% PBS blood grouping A2 erythrocyte!
was added to all the tubes. After mixing, the tubes
were incubated for an additional two hours at room
temperature. They were then screened for microscopic
agglutination. Urinary HCG was used for comparison
and a sample of human blood group A secretor saliva
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TUBE NUMBER 3m1 per tube
Fig.5. Elution pattern of the crude preparation
on Sephadex G-200 column (2x150 cm) in
0.05M NHS}HCO3. The hormonally active
fraction was represented by the shafted
area.
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R E S U L T S
PART A. PURIFICATION OF MOLAR HCC
The total hormonal activity in respect of HCG of
the molar tissue was found to differ from mole to mole.
Usually the activity of the tissue obtained from hys-
terectomy was higher than that from dilating and
curetting management or spontaneous abortion. However,
the average value was found to be around 10,000 IU per
gram dry tissue. HCG activity in hydatidform mole was
found to be equally distributed between the tissue and
the fluid (see appendix B, p. 118). It should be empha-
sized that careful washing to remove blood was essen-
tial for the purification because contaminated blood
waa- difficult to remove at later stages. Caution was
also given to avoid breaking up the vesicles, which
resulted loss of HCG. There was no loss in total act-
ivity after the.treatment of H3PO4 at pH 3.0-, with
the advantage that most blood pigments were removed.
The elution pattern of Sephadex G-200 chromato-
graphy was shown in Fig. 5. Three major peaks were
observed in the chromatography profile. The hormonally














TUBE NUMBER 10ml per fube
Fig. 6. Elution profile of DEAE Sephadex A-50 anion
exchange chromatography. The column (2x30
cm) was eluted with increasing NaCl concen-
tration of the 0.05M tris-phosphate buffer,
pH 8.6 to 0.2M. The hormonally active
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Fig. 7. Elution pattern of DEAE Sephadex A-50 anion
exchange chromatography. The column (2x30
cm) was eluted with increasing NTaCl concen-
tration of the 0.05M tris-phosphate buffer,
pH 7.0, to 0.5M. The hormonally active
fraction was represented by the shaded area.
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third peak. Since we are interested in the sugar
moiety of molar HCG, every precr.ation was taken to
avoid denaturation or hydrolysis.of the Sephadex
gel, which is composed of dextran. A survey.of
literature shows that Sephadex gel is.affected 'at
pH below 2 salt solutions, sodium azide, alkaline
and weakly acidic solutions showed no ,effect (84).
Fig. 6 shows the elution profile of the DEAE
Sephadex A-50 anion exchange chromatography (pH 8.6).
It was equilibrated and eluted with 0.05 M tris-phos-
piate buffer, pH 8.6. The active fraction was eluted
between 0.1 M and 0.2 M NaCl. The flow rate was
adjusted at 40 ml/hr. and two days were required for
the rin. The flow rate was relatively low because
DEAE Sephadex A-50, being a large, strongly swollen
ion exchanger was therefore more tightly packed leading
to reduced flow rates than A-25 type.
The elution pattern of the DEAE Sephadex A-50
anion exchange chromatography (pH 7.0) is shown in
Fig. 7. The active fraction was eluted between 0.01
M to 0.02M, NaCl in 0.05 M tris-phosphate buffer, pH
7.0. The initial flow rate was found to be slow due
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probably to compressible properties of DEAE A-50 resin.
However, throughout the elution with continuous ionic
strength gradients the bed height decreased with in-
creasing salt concentration, giving rise to a steadily
increasing flow rate. The specific activity of the
final product amounted to approximately 7,000 IU/mg by
.immunoassay, using the commercial UCG titration test
kit (Wampole Laboratories, Stamford, Conn., U.S.A.,















Fig. 8 Sodium Dodecyl Sulphate Gel Electrophoresis.
Protein marker A, bovine albumin (67,000).
B, ovalbumin (45,000) C, chymotrypsinogen
-A (25,000) D, myog,lobin (17,800) E,
cytochrome C (12,400).
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PART B. PHYSICAL PROPERTIES OF NCLAR FICG
( I Noleculiar weiht determination
By means of sodium dodecyl su!.phate (SDS) poly-
acrylamide gel electrophoresis, there is a linear.
relationship among the relative mobilities and logarithms
molecular weight of the protein markers, i.e. bovine
albumin, ovalbumin, chymotrypsinogen-.A, myoglobin,
and cytochror:me- C.
The molecular -w-eight of molar HCG was therefore
determined in the absence of 2-mercaptoethanol, while
that of the subunits were determined in the presence
of 2-mercaptoethanol. The apparent molecular weight
of molar HCG was found to be 57, 000 and its subunits,
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Fig. 9. The absorption spectrum of molar HCG




(II) Absorption Spectrurn and Extinction Coefficient
The absorption spectrum of molar HCG in 0.05 M
NH4HCO3 solution was shown in Fig. 9. The maximum
aborption of the hormone was at 280 nm at UV region.
1%
The extinction coefficient F1% Was determined
1cm
on a weight basis. The molar extinction coefficient
1%
E M was calculated from the E 1cm value and the mole-
cular weight of the sample determined by the sodium
dodecyl sulphate (SDS) gel electrophoresis (see p.58).
The results are given in Table 3.
Table 3. Extinction Coefficient of urinary
and molar HCG
1%Glycoprotein E Em (M-1cm-1)1cm
Molar HCG 6.4 3.65 x 10/4
Urinary HCC 1:41 x 104 (85)3.6
5 (86)
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(III) Amino Acid Composition Analysis
The amino acid composition of molar HCG was
determined by means of two time intervals of hydro-
lysis residues of threonine, serine, half-cystine,
methionine and tyrosine values were calculated by
extrapolation to zero time of hydrolysis (105). No
free sulfh ydryl group was discovered, by carboxamido-
methylati.on with iodoacetamide and subsequent hydro-
lysis of the product
Since urinary HCG has been determined as to
contain only 4 histidine residues (39, 40), the amiino
acid composition of molar HCG was therefore recalcu-
lated on the same basis, i.e. on 4 histidine residues
(Table 4). The weight of the polypeptide unit calcu-
lated from its amino acid content wn s 21.000
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Table li. Amino Acid Composition of molar HCG
72-hr. Hy No. of Residues Residues22-hr. hy-Amino
per 100 per 239aminodrolysisdrolysisicid
amino aminoresiduesresidues acid
acidresidues acid
1110.57 13.6 (14)11.40 5.76Lys
2.1044.00 5.0 (5)4.00His
4.438.30 11.2 (11)8.60 9Arg
8.381615.41 19.8 (20)16.56Asp
13c 16.1 (16)7.0311.84Thr 9.49




6.20 14.9 (15)1210.68Ala 12.96
17.3 (17)14c12.20 7.45Half-cys 7.80
17.3 (17)6.971413.1613.43Val
5.0 (5)4c 1.941.99Met 3.10
5.0 (5)1.994Ile 3.783.84
18.6 (19)1513.7214.82Leu 7.49
8.7 (9)6.72Tyr 7c 3.795.53
Phe 6 7.11 (7)6.106.55 3.34
239100Total: 193
a : amino acid residues were calculated on the basis of 4 histidine
residues (39, 40)
b : average of the values at two time intervals to the nearest
integer
Note: since the total amino acid residues in urinary HCG as
determined by Bahl (39, 40) amount to 239, it will
facilitate to compare the results of molar HCG on the












Fig. 10. Paper chromatogram of neutral sugars
in molar HCG hydrolysate. Standard 1,








Fig. 11. Paper-chromatogram of amino sugars
in molar HCG hydrolysate. Standard
1, glucosamine 2, galactosamine.
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PART C, QUALITATIVE AND QUANTITATIVE ANALYSTS
OF CARBOHYDRATE CONTENT OF MOLAR HCG
(I) Qualitative Analysis
(a) Neutral and Amino sugars
Fig. 10 showed the paper chromatogram of neutral
sugars in molar HCG. It could be observed that molar
HCG contains, mannose, galactose and large amount of
glucose. Fucose, because of its minute content, could
not be detected in the. chromatogram.
Since the glucose content is high, it would be
interesting to ascertain its optical forms and Dextro-
stix (Atwes Co., Miles Lab., U.S.A.) was employed, for
this purpose. Dextrostix is a commercially available
reagent strip which determines D-glucose by glucos
oxidase. The result shows straightly positive.
Fig. 11 showed the paper chromatogram of amino
sugars in molar HCG. Glucosatnine a:id. galactosamine





Fig. 12, Gas chromatogram of alditol acetates of
standard neutral sugars on 3% ECNSS-M on
60/80 mesh Gas Chrom Q column.
Peak 1, fucose 2, arabinose 3, mannose




The neutral sugars in the wolar I-KG preparation'
were determined on column 1 (i.e. 3% ECNSS-M on 6o/8o
mesh Gas Chrom Q). A gas chro:iiatogram of.a standard
solution, showing the distinct separation of fucose,
arabinose, mannose, galactose and glucose, and the
relative responses of the flame ionizati'jn detectors
to these five neutral sugars were presented in Fig. •12.
Approximately 0.03 }t mole of each of the above neutral
sugar alditol acetate derivative, using as standards,
was injected into the gas chromatograph in order to
obtain the responses shown. A single- peels was obtained
for the alditol acetate derivative of each sugar'.
Arabinose was used as the internal standard
sugar. The molar response and retention time of




Response Factors and Reten -ion times relative
to arabinose for alditol acetates
of neutral sugars











Fig. 13. Gas chromatogram of alditol acetates of
neutral sugars in molar HCG hydrolysate
on 3% ECNSS-M on 60/80 mesh Gas Chrom Q
column. Peak 1, fucose 2, arabinose




The molar HCG sample was hydrolyzed and the
alditol acetAtoo of the neutral sugars released
were prepared. Arabinose was used as internal sugar.
The gas chromatogram was presented in Fig. 13 The
percentage of each carbohydrate in the hormone was
calculated (79) and listed in Table 6.
Table 6.
Neutral Carbohydrate Content of Molar HCG










Fig. 14. Gas chromatogram of alditol acetates of
standard amino sugars on 3% Poly A-103
on 100/120 mesh Gas Chrom Q column.




The amino sugars in the molar HCG preparation
was determined on column 2 (i.e. 3% Poly A-103 on
100/120 mesh Gas Chrom Q). With this procedure,
symmetrical peaks of the three hexosaimines (i.e.
glucosamine, galactosamine and mannosamine) were
obtained. The separation was good a, can be seen
in Fig. 14. Mannosainine was used as the internal
standard sugar. The molar response and retention
time of each carbohydrate relative to niannosamine
wr.re given in Table 7.
Table 7
Response Factor-and Retention times relative.
to Mannosamine for alditol acetate of
amino sugars








Fig. 15. Gas chromatogram of alditol acetates of
amino sugars in molar HCG hydrolysate on
3% Poly A-103 on 100/120 mesh Gas Chrom Q
column. Peak 1, glucosamine 2, galacto-
samine 3, mannosamine (internal standard).
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The molar HCG sample was hydrolyzed and the
alditol. acetates of the amino sugars released were
prepared. Naunosamnine was used as internal stand-
ard sugar. The gas chromatogram was presented in
Fig. 15. The percentage of glucosamine and galacto-
samine in molar HCG sample were also calculated (79)
and. listed in Table 8, whereas that of these two
amino sugars in urinary IICG as reported in literature
is given in table 12 on p. 95.
Table 8
Amino Calbohydrates content in
Molar HCG






























Fig. 16. Determination of amino sugars in molar HCG
hydrolysate by amino acid analyzer (Beckman
Model 120 C). Peak 1, glucosamine 2,
galactosamine.
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The amino sugars of the molar HCG preparation
were also determined by means of amino acid analyzer
(Beckman Model 120 C). The results obtained are given
in Fig. 16, which shows the calibration curve by
.standard glucosamine and galactosamine together with
the concentration of component an.ino sugars in molar
HCG. The results obtained by amino acid analyzer





Fig. 17. Two dimensional double agar gel immuno-
diffusion patterns of urinary and molar
HCG towards urinary HCG antiserum.
Well central, urinary HCG antiserum
1 and 2, urinary HCG 3 and 4, molar
HCG.
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PART D. IMMUNOLOGIC PROPERTIES OF MOLAR HCG
(I) Immunologic Properties of Urinary and molar HCG
Fig. 17 showed the two dimensiona]. double agar
gel immunodiffusion pattern of urinary and rnclar HCG
towards urinary HCG antiserum. Wells 1 and 2 were
urinary HCG while i, ells 3 and It, molar MCC. There a
two smooth fusion lines between 1 and 3, 2 and 4.
Since there are no cross-reactions between 1 and 3 of
2 and 4, it is suggestive that the HCG molecule
isolated from the two sources may have similar peptide
moieties thereby giving similar precipitin lines.
This point will be further discussed and elaborated
at a later stae (see p.102)
(II) ABO Blood Group Activity of Molar HCG
The agglutination inhibition technique (81) was
used to determine the ABO blood group activity of
molar HCG and the results are given in Table 9. The
original titer of anti-A was 32 and that of anti-B was
16. For both urinary and molar HCG, no reduction in
titer of anti-B serum was.ascertained, which indicated
the absence of blood-group B-like site on these two
Table 9. ABO Blood Group Activity of Urinary and Molar HCG
Anti-serum







(I) Original titer of anti-A serum = 32
Titer of anti-A serum + urinary HCG = 0
Titer of anti-A serum + molar HCG = 32
(II) Original titer of anti-B serum = 16
Titer of anti-B serum + urinary HCG = 16
Titer of anti-B serum + molar HCG = 16
Table 10.
Inhibition of A lutination of human anti-A serum by urinary and molar HCG
HCG
Human anti- Saliva from

















Fig. 18. Inhibition of agglutination of group A2 cells
against a non-immune anti-A serum by addition
of urinary HCG (Sigma Chemical Co., Stock no.
CG-10, 10,000 IU per vial, dissolved in 150 ul
PBS solution) in 1:1 dilution under microscope
with low power (x100).
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Fig. 19. Agglutination of group A2 cells against a non-
immune anti-A serum by addition of urinary HCG
(Sigma Chemical Co., Stock no. CG-10, 10,000 IU
per vial, dissolved in 150 jil PBS solution) in
1:512 fold dilution under microscope with low
power (x100).
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Fig. 20. Agglutination of group A2 cells against
a non-immune anti-A serum by addition of
molar HCG (3% w/v) in 1:1 dilution under
microscope with low power (x100).
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molecules of different origins, However, reduction
in titer of anti-A from 32 to 0 by urinary IICG indi-
cated he presence of blood-group A-like sites on this
molecule. But. no change of anti-A titer by inhibition
of molar IICG was detected, that is to say: molar HCG
showed the absence of the blood-group A-like site.
In addition to the above titers obtained by
antiserum dilution, urinary and molar HCG was similarly
serially diluted in order to confirm the above results
(Table 10). It can be seen that molar IICG showed no
agglutination, indicating the absence of the blood-
group. A-like site. However, urinary HCG showed a`glu-
tination up to 1:4 fold dilution. Saliva from a blood
group A secretor was used as control. This finding is
in agreement with the above results. Fig. 18 to 20
indicates the microscopic appearance of the r gglutin-.
ation of group A2 cells, by a non-immune anti-A serum
in low power field (x100). Fig. 18 :bows the inhibi-
tion of agglutination by addition of urinary.HCG in 1:1
dilution. No cell agglutination could be observed.
Fig. 19 indicates the agglutination after the addition
of urinary HCG in 1:512 fold dilution. No inhibition
of agglutination was observed on this dilution which
exceeded the titer of anti-A like activity of urinary
HCG. Fig. 20 shows that no inhibition of agglutination
could be observed by addition of molar HCG in 1:1 dilution.
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D I S C U S S 1 0 N
PART A. PURII'TCATION OF MOLAR 11CG
The method used here to obtain a pure prepara-
tion of molar HCG followed that of Chan, et al.-, 1973
(4 .5). The fractionation includes four major steps
a. Salt precipitation
b. Sephadex G-200 chrorimatography
c. DEAE Sephadex A-50 anion exchar.ge chromat-o-
graphy, pH 8.6
d. DEAE Sephadex A 50 anion exchange chromato-
graphy, p11 7.0.
Since we are interested in the carbohydrate
moiety of molar HCG, every precaution was taken to avoid
denaturation or hydrolysis of the Sephadex gels, which
is composed of dextran. A survey of literature shows
that Sephadex gel is affected at pH below 2 salt
solutions, sodium azide, alkaline and weakly acidic
solutions show no effect (84). Only weakly basic or
neutral buffers were used throughout the fractionation
procedures. It should also be emphasized that the
hormonally active fractions eluted from each column were
concentrated by ultrafiltration and dialyzed extensively
before further purification. Salts or any sugars if
present should therefore be excluded.
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PART B. PHYSICAL PROPEPTIES OF MOLAR HCG
(I) Molecular weight determination
The molecular weight of molar HCG has recently
been determined by Pala et al. (10) it is found to be
63,000, with 27,000 and 35,000 for the component X-
and B-subunits. These authors found that the mole-
cular weight is the same for three different origins,
i.e. (a) hydatidiform mole tissue; (b) urine of molar
patients; (c) plasma of molar patients.
Ashitaka et al. (87) stated that IJCG molecule
obtained from hydatidiform mole tissue, having greater
carbohydrate content, shouli be larger than that from
normal pregnancy. However, the molecular weight of
our highly purified molar HCG preparation was found to
be 57,000.and with two subunits of molecular weight
26,000 and 31,000. The results were smaller than those
obtained by Pala et al. (10).
Though the technique of sodium dodecyl sulphate (SDS)
gel electrophoresis had been widely used as a simple,
reliable method for the estimation of protein mole-
cular weights since its introduction by Shapiro et al.
(88) in 1967, an increasing number of proteins. have
recently been shown to behave anomalously on SDS
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gels (89). Furthermore, it was reported that glyco-
proteins, due to decreased binding of SDS to their
extended saccharid e sidechains, tend to migrate less
than wouJd be expected for their molecular weights
resulting in over-estimation (90). Furthermore, the
molecular weight of a glycoprotein on SDS polyacryl-
amide gels, estimated from a non-glycOprotein stand-
ard curve, should also produce some degree of error.
When glycoproteins become commercially available for
use as markers, this problem will then be easily solved.
More recently in 1973, the amino acid sequence
of urinary I CG of normal pregnancy was determined by
Bahl et al. (39, 40). The molecular weight. of HCG -
was estimated. to be 14,900 as calculated from its
chemical. composition, approximately 10,200 for the
protein and 4, 700 for the carbohydrate part' of the
molecule. The calculated molecular weight of HCG-
was 23,000 16,000 for the protein portion and 7,000
for the carbohydrate.
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(II) Absortion Spectmir and Extinction Coefficient:
The spectrum of the purified molar HCG displayed
only one absorption peak at 280 nm as shown in Fig. 9
no other absorption was detected.
%
The extinction coefficient, E of molar
1cm, 280nm
HCG was found to be 6.4, as given in Table 3,. which is
larger than that of urinary HCG: Morgan et al. (85)
obtained a value of 3.6 whereas Mori et al. (86), 5.5.
In view of the large difference between the above values
of.urinary HCG, it seems premature to comment on the
present comparison between urinary and molar HCG.
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III. Amino__ Acid. Composition Analysis
The amino ac.id sequence of urinary HCG has recently
been established by Bahl et al. (39, 40). Table 11.showed
the amino acid composition of, urinary and molar HCG. The
amino acid composition of molar HCG was presented on the
basis of 4 histidine residues for two reasons:
(a) Histidine has been conventionally chosen to serve as
the basis of calculation because of its stability
during acid hydrolysis (105);
(b) Urinary HCG contains 4 histidine and the present
presentation would facilitate comparative studies.
Table 11 also showed the results of urinary HCC (FSH-like)
obtained by:Ashitaka et al (34) the results are re-calculated
on the basis of 4 histidine. residues for -comparison. From
these data, it can be seen that the content of arginine,
threonine, proline, half-cystine are found to be much lower.
.The most interesting quantitative difference lies in proline:
31 in urinary HCC whereas only 16 in the molar hormone.
However, the result of Ashitaka et al. (34) reveals only
17 proline, which is very close to our finding.
Since the total amino acid residues in urinary HCG
as determined by Bahl (39, 40) amount to 239, it will faci--
litate to compare the results of molar HCG on the total
number of residues. On this basis, the comparison shows
that the contents of arginine (11 versus 15) and threonine
(16 versus 18) are slightly lower whereas proline is still
much lower. (20 versus 31).
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Table 11. Amino Acid Composaton of Urinary and Molar HCG
Urinary HCG Molar HCGAmino Acid
Bahl a Ashitalca b per 193 per 239
(FSH-like) amino acid amino acid
Lysine 10 11 11 13.6 (14)
Histidine 4 4 4 5.0 (5)
Arginine 15 12 9 11.2 (11)
Aspartic acid 17 21 16 19.8 (20)
Threonine 18 14 13 16.1 (16)
20Serine 15 18 22.3 (22)
Glutamic acid 18 23 18 22.3 (22)
Proline 17 1631 19.8 (20)
27Glycine 12 14.9 (15)12
Alanine 13 14 12 14.9 (15)
Half-cystine 22 11 14 17.3 (17)
Valine 18 12 14 17.3 (17)
Methionine 4 4 4 5.4 (5)
Isoleucine 46 5.0 (5)5
18 15Leucine 18.6 (19)11
Tyrosine 8.7 (9)77 9
6Phenylalanine 7.4 (7)6 5
a : Bahl et al. (39, 40)
b : Urinary HCG with FSH-like activity; from Ashitaka et al.
(34), re-calculated on the basis of 4 histidine.
Note : since the total amino acid residues in urinary FICG as
determined by Bahl (39, 40) amount to 239, it will
facilitate to compare the results of molar HCG on the
same total number of residues. Hence this last column
is given.
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PART C QUALITATIVE AND QUANTITATIVE ANALYSIS
OF CARBOHYDRATE CONTENT OF MOLAR HCG
(I) Qualitative Analysi
The carbohydrate components of molar HCG were
qualitatively determined by means of paper chromato-
graphy. Glucose, fucose, miannose, glactose, giuco-.
sarine, gal.actosainine and sialic acid were -present in
the molar HCG hydrolysate. The carbohydrate .moiety.
of the urinary HCG as determined by many workers (7,
8,14, 34) consists of no glucose but all the other
sugars, i.e. fucose, mannose, galactose, giucosamine y
galactosamine and sialic acid are present. The pre-
sence of glucose in the molar TCG hydrolysate was
verified by glucose oxidase-peroxidase enzyme system
to be in optically D-form. Glucose has been found
in glycoprot eins, but not commonly only collagen
and several enzymes have been reported to contain
glucose (28). It should be emphasized that strict
caution has been taken to prevent possible conta-
inination of glucose during purification. In order
to ensure no free glucose being contaminated i we have
carried out further dialysis for 4 days with several
changes of distilled water on our pure product the
result was identical. It can therefore be concluded
that the glucose content is derived from the hormone.
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(II) Quantitative Analysis
The carbohydrate contents of purified urinary
HHCG in normal pregnancy were reported by various
authors using different methods. For the neutral
sugars, paper chromatography together with Chromo-
scan were used by Goverde et al. (144) this tech-
nique could not give reliable results which were
therefore not quoted here. Ashitaka et al. (34) used
colorimetric methods for the analysis. However, this
method yielded only the total but not the individual
neutral and amino sugars and the large quantity of
amino acids contained in the hydrolysate had been
reported to cause interference (77). Bahl (B) esti-
mated the neutral sugars as their triniethylsilyl TMS)
derivatives on gas chromatography. However, when
applied to aqueous solutions of acid hydrolysates of
the hormone, multiple peaks for each sugar (one peak
for each isomer of the sugar present) were obtained.
It has been.more recently shown that the alditol
acetate derivatives of neutral and amino sugars
were amenable to analysis by gas chromatography (75,76,

































Fie. 21. The Preparation of Alditol Acetat
Derivatives of carbohydrates
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satisfactory. This method was therefore adopted
in our present investigation.
Since carbohydrates were labile in acid
solution, at elevated. temperature, the mildest
conditions of acid hydrolysis consistent with
complete cleavage of all glycosidic bonds must be
applied. It was reported by various authors (7,
8, 14, 34) that the neutral sugars in ur inar v IiCC
were completely hydrolyzed by 1 N HCl at 100 for
2 hours. While for amino sugars, 2 N HCl at 1450
for 5 hours was needed. The hydrolysate was free
of amino acid interference after treatment with
Dowex 1 (HCO3-) resin. The a1 ditol acetates of
the carbohydrates were prepared as illustrated in
Fig. 21.
Table 12.
































































The carbohydrate content of our molar HCG
preparation was presented in Table 12 and the data
of urinary, placental and molar HCG by other authors
were also included for comparison. As shown in Table
12, carbohydrate contents differ greatly depending on
the source of HCGW In molar HCG, the total hexose
content is remarkably high, due to the presence of
glucose which amounts to 211.4 g/100 g hormone, i.e.
87% of the total hexose content the other hexoses,
we find, are comparatively lower. Our finding also
shows that the amino sugars are much lower than those
in the urinary HCG.
More recently, the chemistry of glycoproteins
has been widely investigated this is reviewwwred by
Sharon (28). It has been discovered that the carbo-
hydrate side chains of the glycoproteins may serve as
markers or signals for the metabolic control of the
protein by the organism. Other possible roles have
been suggested: oligosaccharides may provide handles,
for example,for the transport of protein from one
part of the cell to another, or they may render the
protein resistant to enzymatic digestion.
The most intriguing of these proposals, however,
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is that the sugars of glycoproteins may be the'
essential component of the mechanism by which cells
recognize other cells and large molecules. These
sugars, perched on the surface of the cell, appear
to act as letters or words in intercellular communi-
cation. The importance of cellular communication is
perhaps best illustrated by its role in the develop--
ment of cancerous growths. The social behavior of
malignact cells is different from that of normal cell,
Normal cells stop growing when they touch each other,
for example, ihereas cancer cells grow without rc-
straint. Much evidence suggests that the trans-
formation that makes malignant cells unresponsive to
such environmental cues is related to a modification
of the cell surface. Recent investigations stron.g.ly
st'ggest that this modification of the surface pro-
perties of the cell involves the sugar side chains
of glycoproteins.
It is now widely acknowledged that the primary
site of action of gonadotropins is the receptors on
the plasma membranes of the target cells (91). All
of the metabolic effects of the hormone are mediated
through this initial interaction with the exterior of
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the cell. The physicochemical nature of the binding
and the mechanism of transduction are not yet knocm.
Urinary HCG binds to the receptors on the plasma
membrane S with an association constant of the order
of 10/10 M-1 (92). The glycoproteins and glycolipids
which are essential components of cell surfaces, play
an important role in diverse cell-surface phenomena
such as interaction with macromolecules, cell. recog-
nition, cell adhesion, and contact inhibition. It is,
therefore, conceivable that the carbohydrate may be
involved in the interaction of the hormone with the
rtceptor or in the various other metabolic functions
including stimulation of adenyl cycles se, steroidoa-
genesis and protein synthesis.
Most recently, the effect of carbohydrate moiety
in urinary HCG on the binding to the plasma membrane
receptors of the rat testes were widely investigated
by Bahl et al. (16). Urinary HCG contains sialic
acid, galactose, mannose, fucose, galactosamine and
glucosamine. It was sequentially hydrolyzed with
purified specific glycosidases. The resulting.modified
forms of HCG were examined for their ability to com-
pete for binding to the membrane receptors by using
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1251-labeled HCG. It was found that the removal of
sialic acid resulted in a two-fold inerease in the
binding to the plasma membranes. Hydrolysis of
galactose of HCG had greater binding than the native
HCG, but was less active than the desialized IICG.
Subsequent removal of giucosamine did not alter the
binding significantly. However, the hydrolysis of
mannose residues drastically reduced the binding
Bahl et al. (16) suggested that sialic acid, galactose
and glucosamine are not involved in the binding but.
mannose may play an important role on the binding
activity. It must be emphasized that the involvement
of mannose in the interaction of macromolecules to the
cell surfaces and in the intercellular interactions
has been observed recently (93).
The role of the carbohydrate side chain of
urinary HCG in the stimulation of cyclic AMT- and
steroidogen sis has also been determined (16).
Preliminary data showed that all carbohydrate moiet1Ey
on urinary HCG play an important role in the stiinu-
lation of cyclic AMP and steroidogerlesis. Further-
moremore, it was found (16) that the carbohydrate part
of the molecule particularly the sialic acid, galactose,
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N-acetyl-giucosamine and mannose residues did not
act as the antigenic determidanis in immunological
activity.
Molar HCG were found to possess large amounts
of glucose which is absent in urinary HCG. However,
the other hexoses and arnirn.o sugars in molar HCG are
comparatively lower. The qualitative and quantitative
difference in carbohydrate side ,chains between molar
and urinary HCG should not be overlooked. It is
therefore strongly suggestive that HCG secreted from
ncrmal and molar pregnancy may be different in meta-
bolic control. For example, the well-known clinical
fact that HCG circulating in the blood remains much
longer in the case of hydatidiform mole than in normal
pregnancy after the uterine content was evacuated (87).
This may be explained by having different metabolic
control.
We also found that HCG in hydatidiform mole was
equally distributed between the vesicle fluid and the
membrane debris of the molar vesicles (see appendix B,
p.118). these membrane-bound molar I-ICG may then
act as signals in the intercellular communication.
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Molar HCG is found to possess glucose in large content
which is peculiarly different from the normal urinary
HCG. We speculate that this variation in the sugar
side chain of molar HCG may play a part in the modifi-
cation of the surface of trophoblastic cells, and
consequently caused malignant growth.
HCG
The carbohydrate moiety of urinaryAwas found
to contribute no effect on its immunological activity
towards anti-HCG. The amino acid composition of molar
HCG was found similar to urinary HCG (see p.89).
This implied that molar and urinary HCG should hale
similar immunological property towards anti-HCG. This
implication was found to be actual in case (see p.78)
PART D. IMMUNOLOGIC PROPERTTE OF MOLAR HCG
(I) Immunolegic Propertics of urinary and molar HCG
HCC isolated frcm urine and molar tissues were
immunologically similar towards anti-HCC. IICG of
urinary and molar origin has been found to possess
similar amino acid composition with the exception of
proline and cystine (see p. 89) but differ in their
carbohydrate cont ent (see p. 96). However, the
immunologic activity towards anti-HCG is closely
similar, indicating that the immunological properties
of these hormones relate almost entirely to the amino
acid composition but with little or no dependence on
the carbohydrate content (16). This has been discussed
earlier (see p. 101)
(II) ABO Blood Group Activity of molar HCG
Urinary HCG has recently been discovered to
possess blood-group A-like activity (64). However,
such activity could not be found in molar HCC. The
structural component required for the blood-group
A-like activity of urinary HCG has not yet been
determined, but it was believed by Marz et al. (64)
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that the, carbohydrate moiety of urinary 11CC seemed
to be associated with the serological activity.
Since molar HCG shows qualitative and quantiative
differences in carbohydrate from urinary HCG, it
is not surprising that they differ in serological-
properties. It has also been postulated thant the
blood--group A--like activity of urinary HCG might
be involved in the suppression of the immunoresporise
by binding, iii tl.i maternal lymphocytes during the
implantation of the fetus on maternal endometrium
(25). It is by virtue of the blood-group A-like
property of urinary HCG that normal pregnancy can
be ensured. It must be pointed out that all the
serological activity of urinary tlCG was located in
the of subunit (64) which contained no N-acetyl-
gz lactosamine, a necessary component of blood-group
A substance (28). The other exception is the carcino
embryonic antigen (CEA) of the human digestive tumor
which was also found to possess blood--group A--like
activity but did not contain any N-acetyl-galacto-
sarnine (94). The monosaccharide components of CEA,
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with the possible exception of L-fucose, are also pre-
sent in HCG - . It is believed that the overall struct-
ure of the whole or part of the carbohydrate unit of HCG-
and CEA molecules must impart the conlormation necessary
CEA is a glycoprotein primarily found in embryonic tissues.
It is thought to play a key role in the embryo s survival
for the cross-reactivity with blood.group A substance.
by suppressing the maternal immune sys cem (95). However,
CEA which is originally absent from adult normal tissues,
has been. detected in various kinds of tumor (95). It acts
as a tumor-specific- transplantable--antigen to avoid immuno-
logical destruction of the tumor cells by the host. Sine
both HCG- and CEA possess blood-group A-like activity
but with the lack of N-acetyl--galactosacnine, and both HCG
and CEA are thought to have similar immunosuppressive res-
ponse to lymphocytes, they may possess some structural
similarities.
The cause of hydatidform mole, a disorder degeneration
of the placenta, is unknown there are good reasons to be-
lieve that it depends on defective development of the
embryo itself rather than on nutritional abnormalities of
the mother. Usually the embryo becomes degenerated.
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absorbed, or otherwise distorted to the point where
it can no longer be recognized. Some authorities
(96) believed that molar changes follow rather than
precede fetal death. The theories of causation are:
a Death of the fetus results in f aiiure of
the circulation in the villi and therefore
in edema and liquefaction of the strorna
b. 4 primary error in the development of the
fetal vessels causes tho villi to become
overloaded with fluid and food stuffs.
I. was demonstrated that (97) the key to the develop
nient of a typical hydatidifornm mole was some deformity
of the ovum or early death of the fetus. In a typical
hydatidiform mole case the embryo ceases developing.
during the third and fourth week of its growth (5th
to 6th week of pregnancy). It is at this stage that.
the vessels of the villi begin to form continuous
channels, the trophoblast is active, and the villi are
large and edematous. When the embryo dies or disappears,
the chorion keeps on growing before abortion occurs,
but the vessels of the villi do not develop. The
primitive vessels or anlagen that have developed
regress and disappear. Since the trophoblast remains
active, however, the villi continue to function
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normally but because of lack of blood vessels, their
inhibition or secretion products accumulate resulting
in edema and cystic change.
We found that the molar HCG produced by a patient
bearing hydatidiform mole possessed no blood-group A-
like., ctivity. The fetus may then, as a result, lose
the surveillance against the rziaternal' immune system.
This may, it seems reasonable to speculate, cause the
early death of the fetus, and consequently the form-
ation of h.ydatidiform mole.
The antigens of the ABO blood group system are
well-known to be important in transplantation. HCG
molecules in normal pregnant urine were found to
possess blood-group A-like activity however, this
property was found to be absent in molar pregnancy.
It seemed reasonable to ekamine the possibility of
the cause of molar pregnancy in terms of blood group
ABO compatibility. We have analyzed data from 44
Chinese patients of hydatidiforin mole confirmed
histologically during 1971-74 at the Gynaecology
Unit B, Queen Elizabeth Hospital, Bong Kong. The
data are shown in Table 13. When comparing with the
data of the ABO blood group frequency in Chinese
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Table 13. ABO Blood Group Distribution of
Hydatidiform mole patients














population in Hong Kong (Table 14, kindly provided
by the British Fled Cross Society, Hong Kong Branch)
no significant change in. the ABO blood group distri.
bution was observed. Data for patients with hydati-
diform mole have also recently been provided by
Dawood et al. (98) at Singapore and Bagshawe (99) at
Britain. Both these authors found no significant
shift in the ABO blood group distribution. .These
data from different geographical locations and nations
lead to a conclusion that the causation of hydati diform
mole may not be due to AB) blood group compatibility.
The genital form of Type 2 herpes simplex are
commonly found on the cervix end vaginal walls of
infected women Nahmias and Frenkel (100) established
a convincing association between the Type 2 herpes
simplex virus and cancer of the cervix. Since the
incidence of zydatidiform mole to become chorioa-
carcinoma is extremely high (96, 97), it seems reason-
able to examine whether herpes virus is present in
hydatidiform mole (see appendix C, p.119). Preliminary
result shows that no virus-like particles can be




The properties of HCG in hydatidiform mole have been
further investigated in the present studies. The results
are tabled below yid compared with ti:ose of urinary HCG
in normal pregnancy as obtained.by other workers.
Table 15. Physico-chemical Properties of
Urinary and Molar HCG
Urinary HCG Molar HCG
3.0 (101, 106)(1) Isoelectric point 4.2 (4, 5)
4.3 (102)
(2) Molecular weight 5.9x104 (8) 5.7x10
(3) Snbunits molecular 3.5x10 3.1x10(10)
weight 2.7x10 2.6x10
(4) N-terminal amino acid Ser & Ala (8) Ser Ala (4, 5)
6.4(5) Extinction coefficient 3.6 (85)
(E1%) 5.5 (86)1cm, 280nm











There are definite differences between HCG of
the two different sources:
(a) The total carbohydrate content in molar HCC
is higher
(b) Glucose is present in molar HCG but absent
in urinary HHCG
(c) Blood-group A-like activity is detectable
in urinary HCG but not in molar HCG.
The amino acid composition of molar HCG displays
close similarities to urinary HCG except for proline
and half-cystine. The N--terminal amino acids of two
subunits of molar HCG were found-to be the same as
those in the urinary HCG.
Our molar HCG preparation showed qualitative and
quantitative differences in carbohydrate moiety from
urinary HCG. It is most significant to note that high
glucose content (i.e. 24.4% by dry weight) is present
in molar HCG, which is found absent in urinary HCG.
It was also found that about half of the molar HCG
content in vesicleswas located on the trophoblastic
membrane (see appendix B, p. 118). We speculate that
these membrane-bound molar HCG may act'as signals in
intercellular communication. Qualitative and quanti-
tative variation in the carbohydrate side chain of
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molar HCG may be responsive to the modification of
the trophoblastic cells surface. This transformation
of the surface properties of the cells may cause the
malignant growth of the trophoblas.t as a result, HCG
produced in normal and. molar pregnancy may probably
,be responsive differently to metabolic control. For
example, the well-know-m clinical fact that HCG circu-
lating in the blood remains much longer in the case of
hydatidiform mole than in normal pregnancy after the
uterine content was evacuated (87). This has been
explained by having different metabolic control (87).
Urinary HCG has been discovered to possess blood-
group A-like activity (64). However, we found that
this property s absent in molar HCG. The dissimilar-
ity of blood-group activity may also be due to their
discrepancy in the carbohydrate content. The serologi-
cal activity of urinary HCG is believed to be associated
with the suppression of the innunoresponse during
.implantation (25, 64). It is by virtue of this blood-
group A-like activity of. urinary HCG that normal preg-
nancy can be ensured. However, the absence of this
serological properties of HCG of molar origin may cause
the fetus to lose its surveillance against the maternal
immune Av4tem This. we consider. may play a part on
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the causation of hydatidiform mole.
Further studies on molar FICG in the following
lines are suggested, which, we believe, may-help better
understanding of this placental disorder.
(a) Separation of molar HCG into its subunits
is of importance, following which the amino
acid sequence may be ascertained. As a
result, the primary structure of molar and
urinary HCG of normal pregnancy can be
studied on a comparative basis-,
(b) The carbohydrate moiety of molar HCG was
found to differ, qualitatively and quancita-
tively, from urinary HCG. It seems important
to further investigate whether this discre
pancy can be related to the difference in
their biological and serological properties
(c) Urinary HCG has been found to possess immuno-
suppressive properties which is believed to
be due to its blood-group A-like activity.
However, molar HCG was found to have no
such serological property. Whether this is
one of the causes of hydatidiforim mole is
important for understanding this placental
disorder
113
(d) HCG in hydatidiform mole tissue is found to
possess no blood-group A-like activity. It
seems important to investigate this serological
property in urinary -HCG of molar pregnancy,
which may have potential value in .clinical
diagnosis
(e) To compare the effect of HCG isolated from
normal and molar pregnancy (in urine, plasma
and tissue) on interaction with lymphocytes,
which will provide important information in
the understanding of this placental disorder
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A P P D I C E S
f A) CHEMICAL STUDIES ON MOLAR FLUID
R) DISTRIBUTION OF HCG IN MOLAR VLSICLES:
FLUID AND CELL DEBRIS
(C) ELECTRON MICROSCOPIC EXAMINATION OF
VIRUS IN MOLAR TISSUE
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APPENDIX A
CHEMICAL STUDIES ON MOLAR FLUID
The cause of the formation of hydatidiforrn
mole is still not known. By micr3scopic examination
,of the molar tissue, it is usually found that the
chorionic villa are cystically dilated and lined by
hyperplastic syncytial trophoblasts. It is believed
that the fluid within the cysts is transported from
the niater.aal plasma through the trophoblasts. It
seems important, therefore, to analyze the molar fluid
with the hope that more understanding of the formation
of such chorionic cysts could be achieved. The molar
tissues were obtained from hysterectomy, spontaneous
abortion or surgical intervention. The untreated
molar fluid was carefully collected with a syringe.
The chemistry of the fluid was determined and the
results are given in Table 16.
As shown in Table 16, the concentration of
H+, Na+, K+,_Cl, Ca++ and urea nitrogen in the molar
fluid were found to be similar to that in the normal
serum.- However, glucose, protein and the lipid content
in the molar fluid were comparatively low and no tri-
glyceride could be found. The HCG content in the molar
fluid amounted to approximately 250 IU/ml.
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Table 16. Chemistry of Molar Fluid in
comparison with Normal Human
Seum
Normal Serum' (103)Mole Fluid
7.31-7.457.45(1) pH
135-155 mEq/1129 mEq/1(2) Na'
3.9.5.5 mEq/18.5 rEq/1(3) K+
98-109 niEq/199 rEq/l(4) c1-
(5) Ca++ 4.6-5.5 mEq/13.6 mEq/1
6.6-3.3 g/lOOml1.0 g/loonil(6) Total protein
3.5-5.0 g/100mlAlbumin o.8 g/looml
0.2 g/ l OOrul 1.6-4.8 g/100m1Globulin
8-24 mg/100ml29 mg/1OOm1(7) Urea nitrogen
70-110 mg/100ml14 mg/ l00rrrl(8) Glucose
450-1000 nig/100ml57 mg/ 100rl(9) Total lipids
30-135 rig/100mlNil(10) Triglycerides
Nil9't 0 TU/ml(11) HCG content
Table 17. Location of HHC in Molar Vesicles
Wet wt. Dry wt, of water. Specific Totalof protein
in dry wt activity activity
Follicular
2 400 mg 80% 26% 16 lu/mg 1,700 IU
membrane (105 mg)
Follicular 25 IU/ms 1,900 IU200 mg 97% 38%7gfluid (76 mg)
Comparison in dry weight basis:
Protein content
Follicular membrane/fc licular fluid= 2
HCG total concentration (expressed by means of total activity)
Follicular membrane/follicular fluid'= 1
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APPENDIX B
DISTRIBUTION OF HCG IN MOLAR VESICLES FLUID
AND CELL DEBRIS
It was speculated by Ashitaka et al. (87) that
HCG of tumor origin might not be released with ease
from the trophoblastic cells. In order to clarify this
view, the following experiment was performed. The fluid
obtained from a hystere'Aomy molar tissue was carefully
separated by means of a syringe. The molar membrane
as blended and lyophilized.. The molar fluid was 'also
lyophilized. The content of HCG on the chorion membrane
and in the molar fluid were determined immunological.iy
by means of commerciai immuno-HCG kits, Pregnosticon
Planotest (Organon Inc., West Orange, U.S.A.). The pro-
tein content was determined by Folin method (104)- The
resilts are given in Table 17.
As shown.in Table 17, it should be noted that HCG
is evenly distributed in the fluid and the membrane
O
debris of the molar vesicles.
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APPENDIX C
ELECTROU MICROSCOPIC EXAMINATION OF VIRUS
IN MOLAR TISSUE
The genital form of Type 2 herpes simplex is
Commonly found on the cervix and vaginal walls of
infected women Frenkel et al. (100) established a
convincing association between the Type 2 herpes
simplex virus and cancer of the cervix. Since the
incidence of hydatidiform mole to become choriocar-
cinoma is extremely high (96, 97), it seems reason-
able to examine whether herpes virus is present in
the molar tissue.
The molar tissue obtained from hysterectomy was
carefully washed with cold sterilized saline to remove
blood. 1 ml of the vesicle fluid was removed by mear.s
of a syringe. The total volume was then adjusted to 3
ml with distilled water. Cesium chloride was then added
to make the refractive index of the total solution to be
1.3810, with a density of 1.50 g/ml. The solution was
centrifuged at 30,000 rpm for 22 hours in Beckman L2-
65B ultracentrifuge. The cesium chloride density gradi-
ent was then set up and' fractionated with 0.25 ml per
120
Fig. 22. Electron micrograph of hyaatiaitorm
mole tissue preparation (x77,000).
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tube. The.DNA fraction, having the largest density,
should lo.:ate at the bottom of the centrifuge tube
while the protein fraction with lighter density locate
at the top. The'DNA or RNA virus, if present, with
protein core should have density in between and locate
at the middle of the centrifuge tube. These fractions
after desalted and concentrated with Minicon Macrosolute
Concentrators (Amicon Corp., U.S.A.) were examined by
electron micros-c-opy. Fig. 22 shows the electron micro-
scope photograph. Virus-like particles were not detected
in the preparation.
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